Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.09 - Poster Session 1 - Combined Modality

    • Type: Poster Session
    • Track: Combined Modality
    • Presentations: 22
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.09-009 - Preliminary Safety and Treatment Delivery Data During Concurrent Phase of Chemoradiation Therapy of the PROCLAIM Trial: A Phase 3 Trial of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Stage III Nonsquamous Cell Lung Cancer.

      09:30 - 09:30  |  Author(s): E. Vokes

      • Abstract

      Loading...

  • +

    P1.10 - Poster Session 1 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 57
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.10-004 - Exploratory Subset Analysis in African Americans from the PointBreak Study (Randomized Phase 3 Pemetrexed + Carboplatin + Bevacizumab Followed by Maintenance Pemetrexed + Bevacizumab Versus Paclitaxel + Carboplatin + Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB/ IV   Nonsquamous Non-Small Cell Lung Cancer)

      09:30 - 09:30  |  Author(s): C. Reynolds

      • Abstract

      Loading...

    • +

      P1.10-033 - Safety and Resource Use in PRONOUNCE: A randomized, phase 3, open-label study of Pemetrexed plus Carboplatin with maintenance Pemetrexed (PemC) and Paclitaxel plus Carboplatin plus Bevacizumab with maintenance Bevacizumab (PCB) in patients with advanced non-squamous (NS) non-small-cell lung cancer (NSCLC)

      09:30 - 09:30  |  Author(s): H.J. Ross

      • Abstract

      Loading...

  • +

    MS11 - Next Generation Technology for Detection and Treatment of Lung Cancer

    • Type: Mini Symposia
    • Track: Biology
    • Presentations: 5
    • Moderators:S. Toyooka
    • Coordinates: 10/29/2013, 14:00 - 15:30, Bayside Auditorium B, Level 1
  • +

    O27 - Clinical Trials and Practice

    • Type: Oral Abstract Session
    • Track: Other Topics
    • Presentations: 8
    • Moderators:J.S. Lee
    • Coordinates: 10/29/2013, 16:15 - 17:45, Bayside Auditorium A, Level 1
    • +

      O27.05 - Is primary tumor standardized uptake value (SUV) an independent prognostic factor for non-small cell lung cancer (NSCLC)? A meta-analysis based on individual patients data.

      17:00 - 17:10  |  Author(s): M. Paesmans

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PL05 - Genomics: From Research Tool to the Lung Cancer Clinic

    • Type: Plenary Session
    • Track: Pathology
    • Presentations: 5
    • Moderators:P. Goldstraw
    • Coordinates: 10/30/2013, 16:15 - 17:45, Plenary Hall, Ground Level
    • +

      PL05.1 - Implications of the Lung Cancer Genome Sequencing

      16:20 - 16:45  |  Author(s): R. Govindan

      • Abstract

      No abstract available for this presentation

    • +

      PL05.3 - Challenges for the Clinician

      17:10 - 17:35  |  Author(s): S. Devarakonda

      • Abstract

      Loading...